Clinical outcomes of delayed start of trastuzumab treatment in patients with early breast cancer: ml25232 study

Autor:	Timur Ceric, I. Marjanovic, A. Cardzic, N. Mahic, Semir Beslija, A. Kurtovic-Kozaric, Anes Pasic, Berisa Hasanbegovic, A. Mekic-Abazovic, M. Kalamujic, J. Alidzanovic
Rok vydání:	2017
Předmět:	Oncology medicine.medical_specialty business.industry Hematology medicine.disease Breast cancer Trastuzumab Internal medicine medicine In patient business medicine.drug Early breast cancer
Zdroj:	Annals of Oncology. 28:v52
ISSN:	0923-7534
DOI:	10.1093/annonc/mdx362.026
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::8273131436589a91485cc8af6cd2d646 https://doi.org/10.1093/annonc/mdx362.026 Zobrazit plný text záznamu